探索乳腺癌的分子机制网络通过多omics分析
Wei Jiang1, Yanjun Zhang2, Qiuqiong Wang3
1Department of Anesthesiology, Yongchuan Hospital of Chongqing Medical University, Chongqing, China.
Asia-Pacific journal of clinical oncology
|March 13, 2024
概括
这项研究确定了乳腺癌 (BC) 进展中的四个关键基因. 这些基因与免疫细胞透和化疗敏感性有关,为BC.提供了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
背景情况:
- 乳腺癌 (BC) 仍然是全球女性的主要恶性瘤.
- 需要对BC分子标和启动/进展机制进行全面的研究.
研究的目的:
- 研究与乳腺癌预后相关的分子网络.
- 确定关键基因及其在瘤进展及其瘤微环境中的作用.
主要方法:
- 在GSE20685数据集上进行权重基因同表达网络分析 (WGCNA).
- 功能性丰富分析 (基因本体学,KEGG).
- 使用公共数据库分析免疫透和药物敏感性.
主要成果:
- 确定了四个核心基因,这些基因对BC进展至关重要.
- 证明了枢纽基因表达与CD4+ T细胞透之间的相关性.
- 发现中心基因对化学疗法药物的敏感性,如AKT抑制剂VIII和Erlotinib.
- 与瘤突变负担和微卫星不稳定性相关的基因表达 (SFRP1,MIA,KRT14).
结论:
- 确定了BC进展的四个关键基因,潜在的治疗点.
- 突出了BC,免疫微环境和化疗敏感性之间的复杂相互作用.
更多相关视频
相关概念视频
Genomics
36.3K
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
36.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K


